Medical Care

Global Venous Thromboembolism Therapeutics Market Research Report 2024

The Venous Thromboembolism Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Venous Thromboembolism Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venous Thromboembolism Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb (BMS)
Bayer HealthCare
Pfizer
Leo Pharma
Portola Pharmaceuticals
ThromboGenics
Ionis Pharmaceuticals
GlycoMimetics
BioInvent International
Segment by Type
Factor Xa Inhibitors
Direct Thrombin Inhibitors
Heparin
Vitamin K Antagonists
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Venous Thromboembolism Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Factor Xa Inhibitors
1.2.3 Direct Thrombin Inhibitors
1.2.4 Heparin
1.2.5 Vitamin K Antagonists
1.2.6 Other
1.3 Market by Application
1.3.1 Global Venous Thromboembolism Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Venous Thromboembolism Therapeutics Market Perspective (2019-2030)
2.2 Venous Thromboembolism Therapeutics Growth Trends by Region
2.2.1 Global Venous Thromboembolism Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Venous Thromboembolism Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Venous Thromboembolism Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Venous Thromboembolism Therapeutics Market Dynamics
2.3.1 Venous Thromboembolism Therapeutics Industry Trends
2.3.2 Venous Thromboembolism Therapeutics Market Drivers
2.3.3 Venous Thromboembolism Therapeutics Market Challenges
2.3.4 Venous Thromboembolism Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue
3.1.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Venous Thromboembolism Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Venous Thromboembolism Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Venous Thromboembolism Therapeutics Revenue
3.4 Global Venous Thromboembolism Therapeutics Market Concentration Ratio
3.4.1 Global Venous Thromboembolism Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Venous Thromboembolism Therapeutics Revenue in 2023
3.5 Venous Thromboembolism Therapeutics Key Players Head office and Area Served
3.6 Key Players Venous Thromboembolism Therapeutics Product Solution and Service
3.7 Date of Enter into Venous Thromboembolism Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Venous Thromboembolism Therapeutics Breakdown Data by Type
4.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2025-2030)
5 Venous Thromboembolism Therapeutics Breakdown Data by Application
5.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Venous Thromboembolism Therapeutics Market Size (2019-2030)
6.2 North America Venous Thromboembolism Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Venous Thromboembolism Therapeutics Market Size by Country (2019-2024)
6.4 North America Venous Thromboembolism Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Venous Thromboembolism Therapeutics Market Size (2019-2030)
7.2 Europe Venous Thromboembolism Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Venous Thromboembolism Therapeutics Market Size by Country (2019-2024)
7.4 Europe Venous Thromboembolism Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Venous Thromboembolism Therapeutics Market Size (2019-2030)
9.2 Latin America Venous Thromboembolism Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Venous Thromboembolism Therapeutics Introduction
11.1.4 Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Venous Thromboembolism Therapeutics Introduction
11.2.4 Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Venous Thromboembolism Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Detail
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Venous Thromboembolism Therapeutics Introduction
11.4.4 Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.4.5 Daiichi Sankyo Recent Development
11.5 Bristol-Myers Squibb (BMS)
11.5.1 Bristol-Myers Squibb (BMS) Company Detail
11.5.2 Bristol-Myers Squibb (BMS) Business Overview
11.5.3 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Introduction
11.5.4 Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.5.5 Bristol-Myers Squibb (BMS) Recent Development
11.6 Bayer HealthCare
11.6.1 Bayer HealthCare Company Detail
11.6.2 Bayer HealthCare Business Overview
11.6.3 Bayer HealthCare Venous Thromboembolism Therapeutics Introduction
11.6.4 Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.6.5 Bayer HealthCare Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Venous Thromboembolism Therapeutics Introduction
11.7.4 Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Leo Pharma
11.8.1 Leo Pharma Company Detail
11.8.2 Leo Pharma Business Overview
11.8.3 Leo Pharma Venous Thromboembolism Therapeutics Introduction
11.8.4 Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.8.5 Leo Pharma Recent Development
11.9 Portola Pharmaceuticals
11.9.1 Portola Pharmaceuticals Company Detail
11.9.2 Portola Pharmaceuticals Business Overview
11.9.3 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Introduction
11.9.4 Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.9.5 Portola Pharmaceuticals Recent Development
11.10 ThromboGenics
11.10.1 ThromboGenics Company Detail
11.10.2 ThromboGenics Business Overview
11.10.3 ThromboGenics Venous Thromboembolism Therapeutics Introduction
11.10.4 ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.10.5 ThromboGenics Recent Development
11.11 Ionis Pharmaceuticals
11.11.1 Ionis Pharmaceuticals Company Detail
11.11.2 Ionis Pharmaceuticals Business Overview
11.11.3 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Introduction
11.11.4 Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.11.5 Ionis Pharmaceuticals Recent Development
11.12 GlycoMimetics
11.12.1 GlycoMimetics Company Detail
11.12.2 GlycoMimetics Business Overview
11.12.3 GlycoMimetics Venous Thromboembolism Therapeutics Introduction
11.12.4 GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.12.5 GlycoMimetics Recent Development
11.13 BioInvent International
11.13.1 BioInvent International Company Detail
11.13.2 BioInvent International Business Overview
11.13.3 BioInvent International Venous Thromboembolism Therapeutics Introduction
11.13.4 BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2019-2024)
11.13.5 BioInvent International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Factor Xa Inhibitors
Table 3. Key Players of Direct Thrombin Inhibitors
Table 4. Key Players of Heparin
Table 5. Key Players of Vitamin K Antagonists
Table 6. Key Players of Other
Table 7. Global Venous Thromboembolism Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Venous Thromboembolism Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Venous Thromboembolism Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Venous Thromboembolism Therapeutics Market Share by Region (2019-2024)
Table 11. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Venous Thromboembolism Therapeutics Market Share by Region (2025-2030)
Table 13. Venous Thromboembolism Therapeutics Market Trends
Table 14. Venous Thromboembolism Therapeutics Market Drivers
Table 15. Venous Thromboembolism Therapeutics Market Challenges
Table 16. Venous Thromboembolism Therapeutics Market Restraints
Table 17. Global Venous Thromboembolism Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Venous Thromboembolism Therapeutics Market Share by Players (2019-2024)
Table 19. Global Top Venous Thromboembolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapeutics as of 2023)
Table 20. Ranking of Global Top Venous Thromboembolism Therapeutics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Venous Thromboembolism Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Venous Thromboembolism Therapeutics Product Solution and Service
Table 24. Date of Enter into Venous Thromboembolism Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Venous Thromboembolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2019-2024)
Table 28. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2025-2030)
Table 30. Global Venous Thromboembolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Venous Thromboembolism Therapeutics Revenue Market Share by Application (2019-2024)
Table 32. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Venous Thromboembolism Therapeutics Revenue Market Share by Application (2025-2030)
Table 34. North America Venous Thromboembolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Venous Thromboembolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Venous Thromboembolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Venous Thromboembolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Venous Thromboembolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Venous Thromboembolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Venous Thromboembolism Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Venous Thromboembolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Venous Thromboembolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Johnson & Johnson Company Detail
Table 50. Johnson & Johnson Business Overview
Table 51. Johnson & Johnson Venous Thromboembolism Therapeutics Product
Table 52. Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 53. Johnson & Johnson Recent Development
Table 54. Sanofi Company Detail
Table 55. Sanofi Business Overview
Table 56. Sanofi Venous Thromboembolism Therapeutics Product
Table 57. Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 58. Sanofi Recent Development
Table 59. Boehringer Ingelheim Company Detail
Table 60. Boehringer Ingelheim Business Overview
Table 61. Boehringer Ingelheim Venous Thromboembolism Therapeutics Product
Table 62. Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 63. Boehringer Ingelheim Recent Development
Table 64. Daiichi Sankyo Company Detail
Table 65. Daiichi Sankyo Business Overview
Table 66. Daiichi Sankyo Venous Thromboembolism Therapeutics Product
Table 67. Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 68. Daiichi Sankyo Recent Development
Table 69. Bristol-Myers Squibb (BMS) Company Detail
Table 70. Bristol-Myers Squibb (BMS) Business Overview
Table 71. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Product
Table 72. Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Bristol-Myers Squibb (BMS) Recent Development
Table 74. Bayer HealthCare Company Detail
Table 75. Bayer HealthCare Business Overview
Table 76. Bayer HealthCare Venous Thromboembolism Therapeutics Product
Table 77. Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Bayer HealthCare Recent Development
Table 79. Pfizer Company Detail
Table 80. Pfizer Business Overview
Table 81. Pfizer Venous Thromboembolism Therapeutics Product
Table 82. Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Leo Pharma Company Detail
Table 85. Leo Pharma Business Overview
Table 86. Leo Pharma Venous Thromboembolism Therapeutics Product
Table 87. Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 88. Leo Pharma Recent Development
Table 89. Portola Pharmaceuticals Company Detail
Table 90. Portola Pharmaceuticals Business Overview
Table 91. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Product
Table 92. Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 93. Portola Pharmaceuticals Recent Development
Table 94. ThromboGenics Company Detail
Table 95. ThromboGenics Business Overview
Table 96. ThromboGenics Venous Thromboembolism Therapeutics Product
Table 97. ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 98. ThromboGenics Recent Development
Table 99. Ionis Pharmaceuticals Company Detail
Table 100. Ionis Pharmaceuticals Business Overview
Table 101. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Product
Table 102. Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 103. Ionis Pharmaceuticals Recent Development
Table 104. GlycoMimetics Company Detail
Table 105. GlycoMimetics Business Overview
Table 106. GlycoMimetics Venous Thromboembolism Therapeutics Product
Table 107. GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 108. GlycoMimetics Recent Development
Table 109. BioInvent International Company Detail
Table 110. BioInvent International Business Overview
Table 111. BioInvent International Venous Thromboembolism Therapeutics Product
Table 112. BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2019-2024) & (US$ Million)
Table 113. BioInvent International Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Venous Thromboembolism Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Venous Thromboembolism Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Factor Xa Inhibitors Features
Figure 4. Direct Thrombin Inhibitors Features
Figure 5. Heparin Features
Figure 6. Vitamin K Antagonists Features
Figure 7. Other Features
Figure 8. Global Venous Thromboembolism Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Venous Thromboembolism Therapeutics Market Share by Application: 2023 VS 2030
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Other Case Studies
Figure 13. Venous Thromboembolism Therapeutics Report Years Considered
Figure 14. Global Venous Thromboembolism Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Venous Thromboembolism Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Venous Thromboembolism Therapeutics Market Share by Region: 2023 VS 2030
Figure 17. Global Venous Thromboembolism Therapeutics Market Share by Players in 2023
Figure 18. Global Top Venous Thromboembolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapeutics as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Venous Thromboembolism Therapeutics Revenue in 2023
Figure 20. North America Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Venous Thromboembolism Therapeutics Market Share by Country (2019-2030)
Figure 22. United States Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Venous Thromboembolism Therapeutics Market Share by Country (2019-2030)
Figure 26. Germany Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Venous Thromboembolism Therapeutics Market Share by Region (2019-2030)
Figure 34. China Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Venous Thromboembolism Therapeutics Market Share by Country (2019-2030)
Figure 42. Mexico Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Venous Thromboembolism Therapeutics Market Share by Country (2019-2030)
Figure 46. Turkey Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Venous Thromboembolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Johnson & Johnson Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 51. Daiichi Sankyo Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 52. Bristol-Myers Squibb (BMS) Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 53. Bayer HealthCare Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 54. Pfizer Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 55. Leo Pharma Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 56. Portola Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 57. ThromboGenics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 58. Ionis Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 59. GlycoMimetics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 60. BioInvent International Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies